Literature DB >> 30762723

Epilepsy Among Elderly Medicare Beneficiaries: A Validated Approach to Identify Prevalent and Incident Epilepsy.

Lidia M V R Moura1,2,3, Jason R Smith1, Deborah Blacker2,4, Christine Vogeli5, Lee H Schwamm1,3, Andrew J Cole1,3, Sonia Hernandez-Diaz2, John Hsu6,7.   

Abstract

BACKGROUND: Uncertain validity of epilepsy diagnoses within health insurance claims and other large datasets have hindered efforts to study and monitor care at the population level.
OBJECTIVES: To develop and validate prediction models using longitudinal Medicare administrative data to identify patients with actual epilepsy among those with the diagnosis. RESEARCH DESIGN, SUBJECTS, MEASURES: We used linked electronic health records and Medicare administrative data including claims to predict epilepsy status. A neurologist reviewed electronic health record data to assess epilepsy status in a stratified random sample of Medicare beneficiaries aged 65+ years between January 2012 and December 2014. We then reconstructed the full sample using inverse probability sampling weights. We developed prediction models using longitudinal Medicare data, then in a separate sample evaluated the predictive performance of each model, for example, area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity.
RESULTS: Of 20,945 patients in the reconstructed sample, 2.1% had confirmed epilepsy. The best-performing prediction model to identify prevalent epilepsy required epilepsy diagnoses with multiple claims at least 60 days apart, and epilepsy-specific drug claims: AUROC=0.93 [95% confidence interval (CI), 0.90-0.96], and with an 80% diagnostic threshold, sensitivity=87.8% (95% CI, 80.4%-93.2%), specificity=98.4% (95% CI, 98.2%-98.5%). A similar model also performed well in predicting incident epilepsy (k=0.79; 95% CI, 0.66-0.92).
CONCLUSIONS: Prediction models using longitudinal Medicare data perform well in predicting incident and prevalent epilepsy status accurately.

Entities:  

Mesh:

Year:  2019        PMID: 30762723      PMCID: PMC6417929          DOI: 10.1097/MLR.0000000000001072

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  29 in total

1.  Development and validation of a case definition for epilepsy for use with administrative health data.

Authors:  Aylin Y Reid; Christine St Germaine-Smith; Mingfu Liu; Shahnaz Sadiq; Hude Quan; Samuel Wiebe; Peter Faris; Stafford Dean; Nathalie Jetté
Journal:  Epilepsy Res       Date:  2012-06-22       Impact factor: 3.045

2.  Accuracy of claims-based algorithms for epilepsy research: Revealing the unseen performance of claims-based studies.

Authors:  Lidia M V R Moura; Maggie Price; Andrew J Cole; Daniel B Hoch; John Hsu
Journal:  Epilepsia       Date:  2017-02-15       Impact factor: 5.864

3.  Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries.

Authors:  E Faught; J Richman; R Martin; E Funkhouser; R Foushee; P Kratt; Y Kim; K Clements; N Cohen; D Adoboe; R Knowlton; M Pisu
Journal:  Neurology       Date:  2012-01-18       Impact factor: 9.910

4.  Risk factors for falls among elderly persons living in the community.

Authors:  M E Tinetti; M Speechley; S F Ginter
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

Review 5.  Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Authors:  Kirsten M Fiest; Khara M Sauro; Samuel Wiebe; Scott B Patten; Churl-Su Kwon; Jonathan Dykeman; Tamara Pringsheim; Diane L Lorenzetti; Nathalie Jetté
Journal:  Neurology       Date:  2016-12-16       Impact factor: 9.910

6.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.

Authors:  Ingrid E Scheffer; Samuel Berkovic; Giuseppe Capovilla; Mary B Connolly; Jacqueline French; Laura Guilhoto; Edouard Hirsch; Satish Jain; Gary W Mathern; Solomon L Moshé; Douglas R Nordli; Emilio Perucca; Torbjörn Tomson; Samuel Wiebe; Yue-Hua Zhang; Sameer M Zuberi
Journal:  Epilepsia       Date:  2017-03-08       Impact factor: 5.864

7.  An update on the prevalence and incidence of epilepsy among older adults.

Authors:  Queeny Ip; Daniel C Malone; Jenny Chong; Robin B Harris; David M Labiner
Journal:  Epilepsy Res       Date:  2017-12-05       Impact factor: 3.045

Review 8.  Epilepsy in the elderly: scope of the problem.

Authors:  Ilo E Leppik
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 9.  Special considerations in treating the elderly patient with epilepsy.

Authors:  R Eugene Ramsay; A James Rowan; Flavia M Pryor
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

10.  Temporal lobe epilepsy in the elderly.

Authors:  L E Morillo
Journal:  Epilepsy Res Treat       Date:  2011-11-24
View more
  9 in total

1.  Accuracy of ICD-10-CM claims-based definitions for epilepsy and seizure type.

Authors:  Jason R Smith; Felipe J S Jones; Brandy E Fureman; Jeffrey R Buchhalter; Susan T Herman; Neishay Ayub; Christopher McGraw; Sydney S Cash; Daniel B Hoch; Lidia M V R Moura
Journal:  Epilepsy Res       Date:  2020-07-11       Impact factor: 3.045

2.  Adherence to Antiseizure vs Other Medications Among US Medicare Beneficiaries With and Without Epilepsy.

Authors:  Samuel Waller Terman; Wesley T Kerr; Carole E Aubert; Chloe E Hill; Zachary A Marcum; James F Burke
Journal:  Neurology       Date:  2021-12-10       Impact factor: 9.910

3.  Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy.

Authors:  Samuel W Terman; Wesley T Kerr; Zachary A Marcum; Lu Wang; James F Burke
Journal:  Epilepsia       Date:  2021-08-31       Impact factor: 5.864

4.  Changes in the Use of Brand Name and Generic Medications and Total Prescription Cost Among Medicare Beneficiaries With Epilepsy.

Authors:  Samuel Waller Terman; Chun C Lin; Wesley T Kerr; Lindsey B DeLott; Brian C Callaghan; James F Burke
Journal:  Neurology       Date:  2022-06-15       Impact factor: 11.800

5.  Patterns of anticonvulsant use and adverse drug events in older adults.

Authors:  Lidia M V R Moura; Jason R Smith; Zhiyu Yan; Deborah Blacker; Lee H Schwamm; Joseph P Newhouse; Sonia Hernandez-Diaz; John Hsu
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-02       Impact factor: 2.890

6.  Identifying Medicare beneficiaries with dementia.

Authors:  Lidia M V R Moura; Natalia Festa; Mary Price; Margarita Volya; Nicole M Benson; Sahar Zafar; Max Weiss; Deborah Blacker; Sharon-Lise Normand; Joseph P Newhouse; John Hsu
Journal:  J Am Geriatr Soc       Date:  2021-04-26       Impact factor: 7.538

7.  Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.

Authors:  Samuel W Terman; Brett E Youngerman; Hyunmi Choi; James F Burke
Journal:  Epilepsia       Date:  2022-03-25       Impact factor: 6.740

8.  Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study.

Authors:  Samuel W Terman; Joshua D Niznik; Geertruida Slinger; Willem M Otte; Kees P J Braun; Carole E Aubert; Wesley T Kerr; Cynthia M Boyd; James F Burke
Journal:  BMC Neurol       Date:  2022-09-01       Impact factor: 2.903

9.  Definitions of Drug-Resistant Epilepsy for Administrative Claims Data Research.

Authors:  Chloe E Hill; Chun Chieh Lin; Samuel W Terman; Subhendu Rath; Jack M Parent; Lesli E Skolarus; James F Burke
Journal:  Neurology       Date:  2021-07-15       Impact factor: 11.800

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.